The AI Arms Dealer: Nvidia’s Path to $5 Trillion and Beyond
Many AI companies may fail, constituting a bubble burst, but Nvidia remains the central beneficiary of coordinated worldwide AI commitments.
BTC$63,649.00+1.27%
ETH$1,666.20+0.82%
USDT$0.9994+0.08%
USDC$0.9998+0.03%
XRP$1.13+0.57%
SOL$66.88+1.42%
TRX$0.3154+0.82%
FIGR_HELOC$1.03+0.07%
DOGE$0.0864+1.38%
HYPE$58.28+2.33%
USDS$0.9997+0.00%
LEO$9.56-0.55%
RAIN$0.013-0.97%
ZEC$412.41-1.07%
XMR$340.72-11.83%
BTC$63,649.00+1.27%
ETH$1,666.20+0.82%
USDT$0.9994+0.08%
USDC$0.9998+0.03%
XRP$1.13+0.57%
SOL$66.88+1.42%
TRX$0.3154+0.82%
FIGR_HELOC$1.03+0.07%
DOGE$0.0864+1.38%
HYPE$58.28+2.33%
USDS$0.9997+0.00%
LEO$9.56-0.55%
RAIN$0.013-0.97%
ZEC$412.41-1.07%
XMR$340.72-11.83%
Michael Burry’s sizable put options on PLTR suggest cautious skepticism, even as the stock’s memetic narrative fuels speculative buying.
Many AI companies may fail, constituting a bubble burst, but Nvidia remains the central beneficiary of coordinated worldwide AI commitments.
Behind Alphabet’s AI expansion lies a deeper business model: Control-as-a-Service (CaaS).
Even as the dollar weakens, these four dividend-paying powerhouses keep income flowing and portfolios stable.
While Target struggles with declining sales, layoffs and a weakened brand strategy, Walmart entrenches its retail dominance.
Despite tariff shocks and market jitters, 2025 is shaping up as the strongest year for IPOs since the liquidity boom of 2021.
As First Brands’ bankruptcy unravels, signs point to a deeper collateral risk brewing across mid-sized lenders.
As volatile U.S. trade policy exposes a critical vulnerability to China's rare earth dominance, investors are turning to domestic producers like MP Materials and Arafura Rare…
Policy tailwinds and precision medicine breakthroughs are pushing healthcare stocks like Tempus AI and CRISPR Therapeutics into a new era of growth.
With Edge Autonomy and Hera Systems under its belt, Redwire is assembling the tools to lead the new frontier of defense-aligned space tech.
Tesla’s valuation continues to defy traditional metrics, powered less by car sales and more by Elon Musk’s mythos and the company’s steady transformation into an AI…
Lockheed’s defense backlog, Pfizer’s biotech expansion, and Schlumberger’s energy contracts make for safe and potentially lucrative dividend plays heading into year-end.
This deal signals a new era where video games are no longer just entertainment, but strategic assets in global finance and politics.